APA (7th ed.) Citation

Yamuna Devi Bakthavatchalam, Fiza Abdullah, Devishree Srinivasan, Ayyanraj Neeravi, Rani Diana Sahni, Abi Manesh, & Balaji Veeraraghavan. (2024). Can isepamicin be a potential option for extended spectrum beta-lactamases and carbapenemases expressing Escherichia coli? Elsevier.

Chicago Style (17th ed.) Citation

Yamuna Devi Bakthavatchalam, Fiza Abdullah, Devishree Srinivasan, Ayyanraj Neeravi, Rani Diana Sahni, Abi Manesh, and Balaji Veeraraghavan. Can Isepamicin Be a Potential Option for Extended Spectrum Beta-lactamases and Carbapenemases Expressing Escherichia Coli? Elsevier, 2024.

MLA (9th ed.) Citation

Yamuna Devi Bakthavatchalam, et al. Can Isepamicin Be a Potential Option for Extended Spectrum Beta-lactamases and Carbapenemases Expressing Escherichia Coli? Elsevier, 2024.